Australia markets open in 8 hours 5 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.06-0.05 (-0.62%)
At close: 04:00PM EST
8.05 -0.01 (-0.12%)
After hours: 07:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
207,820
48,633
0
0
Operating expenses
Research development
123,240
38,023
10,170
6,675
Selling general and administrative
46,737
21,640
4,438
2,802
Total operating expenses
169,977
59,663
14,608
9,477
Operating income or loss
37,843
-11,030
-14,608
-9,477
Income before tax
38,014
-10,947
-14,034
-9,064
Income from continuing operations
24,714
-10,947
-14,034
-9,064
Net income
24,714
-10,947
-14,034
-9,064
Net income available to common shareholders
24,714
-10,947
-14,034
-9,064
Basic EPS
-
-0.51
-0.32
-0.19
Diluted EPS
-
-0.51
-0.32
-0.19
Basic average shares
-
21,592
43,737
47,293
Diluted average shares
-
21,592
43,737
47,293
EBITDA
-
-11,011
-14,591
-9,460